Last updated on December 2018

A Study to Assess Efficacy Safety Tolerability and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP).

Brief description of study

The purpose of this study is to assess efficacy, safety, tolerability, and pharmacokinetics of ABBV-8E12 in subjects with progressive supranuclear palsy (PSP).

Clinical Study Identifier: NCT02985879

Contact Investigators or Research Sites near you

Start Over


Rocky Mountain Movement Disorders Center /ID# 153397
Englewood, CO United States

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.